About US
Contact us
-
FDA in line for new foreign-inspection powersTheSenate is preparing to reauthorize the FDA's all-important user-fee funding. But that's not all the latest Prescription Drug User Fee Act would do. The FDA would get new powers to police imported d2012/5/22
-
How does pharma's CEO pay rank?We know how pharma CEO pay stacked up within the industry. But how did pharma's 2011 compensation packages compare with those in other industries? The Wall Street Journal answers that question with it2012/5/22
-
Even some domestic firms rail at India's price control planIndia's plan to again put price controls on the majority of the drugs in the country has become a flash point forcompanies there as well as Western drugmakers. The proposal is being debated now an2012/5/21
-
Johnson & Johnson recalls a lot of ImodiumJohnson & Johnson's ($JNJ) McNeil Consumer Healthcare, which has gotten accustomed to recalling products in large quantities, is retrieving a lot of Imodium--nearly 54,000 packages. There is no he2012/5/21
-
Generic floodgates open for Plavix in U.S.Plavix is a blood thinner from Bristol-Myers Squibb ($BMY). Generic Plavix is a Bristol-Myers profits thinner that is going to be produced by just about everybody and their brother. The FDA on Thursd2012/5/18
-
HGS puts 'poison pill' in its arsenal against GSKHuman Genome Sciences ($HGSI) has added a poison pill to its portfolio as it tries to fend off the hostile takeover by its longtime partner GlaxoSmithKline ($GSK). The company says the shareholder-ri2012/5/18
-
NIH taps Genentech drug for pioneering Alzheimer's studyThe NIH will help fund a landmark, $100 million study of Genentech's experimental Alzheimer's treatment crenezumab. Researchers will test the drug in Colombians with a particular genetic mutation, aim2012/5/17
-
Pennsylvania still trying get a slice of J&J Risperdal payoutsAn appeal being heard today on a case seen as the precursor to the mountains of litigation over Johnson & Johnson's ($JNJ) Risperdal may decide whether Pennsylvania will see any of the millions of2012/5/17
-
New discount persuades NICE to bless J&J's ZytigaZytiga will get a green light for U.K. patients after all. Britain's cost-effectiveness watchdog reversed its decision against the Johnson & Johnson ($JNJ) prostate cancer pill, thanks to the comp2012/5/16
-
Top 10 Best-selling Cancer Drugs in 2011Oncology drugs are hot. Scratch beneath the surface of most major drugmakers, and you'll find a host of them in various stages of development, as the upcoming American Society of Clinical Oncology mee2012/5/16